Novel drug prevents common viral disease in stem-cell transplant patients ... HealthCanal.com A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital indicates. Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir ... |
